# Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)

> **NCT04009083** · NA · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 31 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Standard of Care MRI
- **OTHER:** Fluciclovine PET scan added to MRI

## Key facts

- **NCT ID:** NCT04009083
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-19
- **Primary completion:** 2021-01-07
- **Final completion:** 2021-01-07
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2021-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04009083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04009083, "Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04009083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*